Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis.
Journal: Molecular cancer therapeutics
Published: February 06, 2021
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 11, 2020
A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages.
Journal: Immunity
Published: July 18, 2018
Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 06, 2017
Cancer: a new role for non-canonical Hippo signaling.
Journal: Cell research
Published: March 01, 2017
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis.
Journal: Molecular cancer therapeutics
Published: November 30, 2016
Molecular insights into NF2/Merlin tumor suppressor function.
Journal: FEBS letters
Published: February 26, 2014
Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Journal: Cancer cell
Published: July 01, 2013
Rationing livers: the persistence of geographic inequity in organ allocation.
Journal: The virtual mentor : VM
Published: January 29, 2013
Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.
Journal: EMBO reports
Published: April 07, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026